| Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes JHF Falkenburg, AR Wafelman, P Joosten, WM Smit, CAM van Bergen, ... Blood, The Journal of the American Society of Hematology 94 (4), 1201-1208, 1999 | 344 | 1999 |
| Generation of dendritic cells expressing bcr-abl from CD34-positive chronic myeloid leukemia precursor cells WM Smit, M Rijnbeek, CAM van Bergen, RA de Paus, HAW Vervenne, ... Human immunology 53 (2), 216-223, 1997 | 107 | 1997 |
| High-throughput characterization of 10 new minor histocompatibility antigens by whole genome association scanning CAM Van Bergen, CE Rutten, ED Van Der Meijden, ... Cancer research 70 (22), 9073-9083, 2010 | 106 | 2010 |
| Multiple myeloma–reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) gene CAM van Bergen, MGD Kester, I Jedema, MHM Heemskerk, ... Blood 109 (9), 4089-4096, 2007 | 103 | 2007 |
| T cells recognizing leukemic CD34+ progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem … WM Smit, M Rijnbeek, CAM Van Bergen, WE Fibbe, R Willemze, ... Proceedings of the National Academy of Sciences 95 (17), 10152-10157, 1998 | 96 | 1998 |
| Identification of 4 new HLA-DR–restricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity AN Stumpf, ED van der Meijden, CAM van Bergen, R Willemze, ... Blood, The Journal of the American Society of Hematology 114 (17), 3684-3692, 2009 | 80 | 2009 |
| HLA class II upregulation during viral infection leads to HLA-DP–directed graft-versus-host disease after CD4+ donor lymphocyte infusion S Stevanović, CAM van Bergen, SAP van Luxemburg-Heijs, ... Blood, The Journal of the American Society of Hematology 122 (11), 1963-1973, 2013 | 70 | 2013 |
| Autosomal minor histocompatibility antigens: how genetic variants create diversity in immune targets M Griffioen, CAM van Bergen, JH Falkenburg Frontiers in immunology 7, 100, 2016 | 63 | 2016 |
| Allo-HLA–reactive T cells inducing graft-versus-host disease are single peptide specific AL Amir, DM van der Steen, RS Hagedoorn, MGD Kester, ... Blood, The Journal of the American Society of Hematology 118 (26), 6733-6742, 2011 | 59 | 2011 |
| Lectins from opportunistic bacteria interact with acquired variable-region glycans of surface immunoglobulin in follicular lymphoma D Schneider, M Dühren-von Minden, A Alkhatib, C Setz, CAM van Bergen, ... Blood 125 (21), 3287-3296, 2015 | 57 | 2015 |
| Phase I/II feasibility study evaluating the generation of leukemia-reactive cytotoxic T lymphocyte lines for treatment of patients with relapsed leukemia after allogeneic stem … E Marijt, A Wafelman, M van der Hoorn, C van Bergen, R Bongaerts, ... haematologica 92 (1), 72-80, 2007 | 52 | 2007 |
| Selective graft-versus-leukemia depends on magnitude and diversity of the alloreactive T cell response CAM van Bergen, SAP van Luxemburg-Heijs, LC de Wreede, M Eefting, ... The Journal of clinical investigation 127 (2), 517-529, 2017 | 51 | 2017 |
| Patient HLA-DP–Specific CD4+ T Cells from HLA-DPB1–Mismatched Donor Lymphocyte Infusion Can Induce Graft-versus-Leukemia Reactivity in the Presence or Absence of Graft-versus … CE Rutten, SAP van Luxemburg-Heijs, CJM Halkes, CAM van Bergen, ... Biology of Blood and Marrow Transplantation 19 (1), 40-48, 2013 | 51 | 2013 |
| Generation of leukemia-reactive cytotoxic T lymphocytes from HLA-identical donors of patients with chronic myeloid leukemia using modifications of a limiting dilution assay WM Smit, M Rijnbeek, CAM Van Bergen, R Willemze, JHF Falkenburg Bone marrow transplantation 21 (6), 553-560, 1998 | 41 | 1998 |
| Identification of 4 novel HLA-B* 40: 01 restricted minor histocompatibility antigens and their potential as targets for graft-versus-leukemia reactivity M Griffioen, MW Honders, ED van der Meijden, SAP van Luxemburg-Heijs, ... Haematologica 97 (8), 1196, 2012 | 38 | 2012 |
| Proteosomal degradation of BCR/ABL protein can generate an HLA-A* 0301-restricted peptide, but high-avidity T cells recognizing this leukemia-specific antigen were not demonstrated EF Posthuma, CA Van Bergen, MG Kester, RA de Paus, PA van Veelen, ... haematologica 89 (9), 1062-1071, 2004 | 36 | 2004 |
| Discovery of T cell epitopes implementing HLA-peptidomics into a reverse immunology approach P Hombrink, C Hassan, MGD Kester, AH de Ru, CAM van Bergen, ... The Journal of Immunology 190 (8), 3869-3877, 2013 | 35 | 2013 |
| CD4+ T-cell alloreactivity toward mismatched HLA class II alleles early after double umbilical cord blood transplantation CHJ Lamers, R Wijers, CAM van Bergen, JAE Somers, E Braakman, ... Blood 128 (17), 2165-2174, 2016 | 27 | 2016 |
| Common minor histocompatibility antigen discovery based upon patient clinical outcomes and genomic data PM Armistead, S Liang, H Li, S Lu, CAM Van Bergen, G Alatrash, LS John, ... PloS one 6 (8), e23217, 2011 | 23 | 2011 |
| Identification of biological relevant minor histocompatibility antigens within the B-lymphocyte–derived HLA-ligandome using a reverse immunology approach P Hombrink, C Hassan, MGD Kester, L Jahn, MJ Pont, AH de Ru, ... Clinical Cancer Research 21 (9), 2177-2186, 2015 | 22 | 2015 |
